clinical development
Four steps to improve the drug development process
November 18 by Pharma IQPharma IQ takes a look at how the drug discovery process can be improved
Keeping tabs on pharma: Synthetic data unlocks potential in clinical trial development and dietary supplements renders coronavirus less infective
March 26 by Emily UwemedimoFind out how a dietary study uncovered a solution that could prevent the SARS-CoV-2 virus from infecting other cells
63% of Pharmaceutical Experts Expect Outsourcing Activity to Increase
January 11 by Pharmaceuticals & Biotechnology EditorWith increasing pressure on pharmaceutical organisations to cut costs and streamline processes, many are deciding to outsource clinical trials. In the current economic climate, outsourcers can provi...
Emerging Markets Clinical Trials: Asia Harnessing the Best of the East and the West to Advance Clinical Development
September 15 by Pharma IQThe buzz around Asia as a clinical trial location is growing and the advantages of carrying out drug development for many can be summed up as lower costs and greater patient pools. Although figur...
Increasing Efficiency in Drug Discovery & Development with Aptuit Medicines Research Centre
September 07 by Andrea CharlesIn this podcast Mark Hembarsky, Vice President and Site Leader of the Aptuit Medicines Research Centre in Verona, Italy, and his colleagues Mauro Corsi, Head of Assay Development and In Vitro Profilin...
The Importance of Innovation in Trial Design
August 02 by Pharma IQClinical development is expensive, invariably high risk and at times enormously inefficient, which is most likely the reason why productivity is sliding so rapidly in the pharmaceutical industry. Wh...
3 Ways to Incorporate Adaptive Trials into Your Oncology Drug Development Plans
June 06 by Andrea CharlesThe lengthy clinical development process of drug development for life threatening diseases is not an optimal development strategy for oncology therapeutic area. Adaptive designs have become popular to...
ITC to clarify the ITC Whitepaper on Clinically Relevant Drug Transporters in London
April 06 by Pharma IQ NewsThis June, Mikko Neimi, ITC member, will meet with European industry experts at Pharma IQ's Clinically Relevant Drug Transporters to discuss the ITC Whitepaper and the imminent FDA guidelines....
Significant Benefits Await those Willing to Embrace Adaptive Methodologies
March 21 by Pharma IQSince the European Medicines Agency and the United States Food and Drug Administration (FDA) clarified their positions on adaptive clinical trials, their use has become more widely accepted within t...
Maximising Efficiency in Clinical Outsourcing
March 08 by Pharma IQDriving clinical development and speeding time to market through effective relationship management will be two of the key themes discussed at Pharma IQ’s 2nd Annual Global Clinical Outsourcing...
Early Phase Trials: Reevaluating Asian Markets
February 10 by Pharma IQMuch has been made in recent years of the shift of research and development (R&D) activities, and in particular the movement of clinical trials to Asia and its rapidly expanding emerging markets...
Oncology Market Leaders Must Look to Clinical Development for Future Growth
November 17 by Pharma IQOver recent years cancer drugs have moved from the traditional chemotherapies, which provided significant side effects, to more targeted therapies. However, according to a recent Reuters rep...